Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Moore, RJ; Doherty, DA; Do, KA; Chamberlain, RM; Khuri, FR
   Racial disparity in survival of patients with squamous cell carcinoma of the oral cavity and pharynx
   ETHNICITY & HEALTH
   
   R.J. Moore et al., "Racial disparity in survival of patients with squamous cell carcinoma of the oral cavity and pharynx", ETHN HEALTH, 6(3-4), 2001, pp. 165-177
2. Shin, DM; Donato, NJ; Perez-Soler, R; Shin, HJC; Wu, JY; Zhang, P; Lawhorn, K; Khuri, FR; Glisson, BS; Myers, J; Clayman, G; Pfister, D; Falcey, J; Waksal, H; Mendelsohn, J; Hong, WK
   Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer
   CLINICAL CANCER RESEARCH
   
   D.M. Shin et al., "Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer", CLIN CANC R, 7(5), 2001, pp. 1204-1213
3. Khuri, FR; Wu, H; Lee, JJ; Kemp, BL; Lotan, R; Lippman, SM; Feng, L; Hong, WK; Xu, XC
   Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer
   CLINICAL CANCER RESEARCH
   
   F.R. Khuri et al., "Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer", CLIN CANC R, 7(4), 2001, pp. 861-867
4. Khuri, FR; Kim, ES; Lee, JJ; Winn, RJ; Benner, SE; Lippman, SM; Fu, KK; Cooper, JS; Vokes, EE; Chamberlain, RM; Williams, B; Pajak, TF; Goepfert, H; Hong, WK
   The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial
   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
   
   F.R. Khuri et al., "The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial", CANC EPID B, 10(8), 2001, pp. 823-829
5. Khuri, FR; Lee, JS; Lippman, SM; Lee, JJ; Kalapurakal, S; Yu, R; Ro, JY; Morice, RC; Hong, WK; Hittelman, WN
   Modulation of proliferating cell nuclear antigen in the bronchial epithelium of smokers
   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
   
   F.R. Khuri et al., "Modulation of proliferating cell nuclear antigen in the bronchial epithelium of smokers", CANC EPID B, 10(4), 2001, pp. 311-318
6. Kim, ES; Khuri, FR; Herbst, RS
   Epidermal growth factor receptor biology (IMC-C225)
   CURRENT OPINION IN ONCOLOGY
   
   E.S. Kim et al., "Epidermal growth factor receptor biology (IMC-C225)", CURR OPIN O, 13(6), 2001, pp. 506-513
7. Khuri, FR; Herbst, RS; Fossella, FV
   Emerging therapies in non-small-cell lung cancer
   ANNALS OF ONCOLOGY
   
   F.R. Khuri et al., "Emerging therapies in non-small-cell lung cancer", ANN ONCOL, 12(6), 2001, pp. 739-744
8. Pisters, KMW; Newman, RA; Coldman, B; Shin, DM; Khuri, FR; Hong, WK; Glisson, BS; Lee, JS
   Phase I trial of oral green tea extract in adult patients with solid tumors
   JOURNAL OF CLINICAL ONCOLOGY
   
   K.M.W. Pisters et al., "Phase I trial of oral green tea extract in adult patients with solid tumors", J CL ONCOL, 19(6), 2001, pp. 1830-1838
9. Shin, DM; Khuri, FR; Murphy, B; Garden, AS; Clayman, G; Francisco, M; Liu, D; Glisson, BS; Ginsberg, L; Papadimitrakopoulou, V; Myers, J; Morrison, W; Gillenwater, A; Ang, KK; Lippman, SM; Goepfert, H; Hong, WK
   Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: Novel bioadjuvant phase II trial
   JOURNAL OF CLINICAL ONCOLOGY
   
   D.M. Shin et al., "Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: Novel bioadjuvant phase II trial", J CL ONCOL, 19(12), 2001, pp. 3010-3017
10. Khuri, FR; Rigas, JR; Figlin, RA; Gralla, RJ; Shin, DM; Munden, R; Fox, N; Huyghe, MR; Kean, Y; Reich, SD; Hong, WK
    Multi-institutional phase I/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancer
    JOURNAL OF CLINICAL ONCOLOGY
    
    F.R. Khuri et al., "Multi-institutional phase I/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancer", J CL ONCOL, 19(10), 2001, pp. 2626-2637
11. Tseng, JE; Glisson, BS; Khuri, FR; Shin, DM; Myers, JN; El-Naggar, AK; Roach, JS; Ginsberg, LE; Thall, PF; Wang, XM; Teddy, S; Lawhorn, KN; Zentgraf, RE; Steinhaus, GD; Pluda, JM; Abbruzzese, JL; Hong, WK; Herbst, RS
    Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck
    CANCER
    
    J.E. Tseng et al., "Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck", CANCER, 92(9), 2001, pp. 2364-2373
12. Shin, DM; Khuri, FR; Glisson, BS; Ginsberg, L; Papadimitrakopoulou, VM; Clayman, G; Lee, JJ; Ang, KK; Lippman, SM; Hong, WK
    Phase II study of paclitaxel, ifosfamide, and carboplatin in patients withrecurrent or metastatic head and neck squamous cell carcinoma
    CANCER
    
    D.M. Shin et al., "Phase II study of paclitaxel, ifosfamide, and carboplatin in patients withrecurrent or metastatic head and neck squamous cell carcinoma", CANCER, 91(7), 2001, pp. 1316-1323
13. Lippman, SM; Lee, JJ; Karp, DD; Vokes, EE; Benner, SE; Goodman, GE; Khuri, FR; Marks, R; Winn, RJ; Fry, W; Graziano, SL; Gandara, DR; Okawara, G; Woodhouse, CL; Williams, B; Perez, C; Kim, HW; Lotan, R; Roth, JA; Hong, WK
    Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer
    JOURNAL OF THE NATIONAL CANCER INSTITUTE
    
    S.M. Lippman et al., "Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer", J NAT CANC, 93(8), 2001, pp. 605-618
14. Lee, JJ; Liu, D; Lee, JS; Kurie, JM; Khuri, FR; Ibarguen, H; Morice, RC; Walsh, G; Ro, JY; Broxson, A; Hong, WK; Hittelman, WN
    Long-term impact of smoking on lung epithelial proliferation in current and former smokers
    JOURNAL OF THE NATIONAL CANCER INSTITUTE
    
    J.J. Lee et al., "Long-term impact of smoking on lung epithelial proliferation in current and former smokers", J NAT CANC, 93(14), 2001, pp. 1081-1088
15. Khuri, FR; Lippman, SH
    Lung cancer chemoprevention
    SEMINARS IN SURGICAL ONCOLOGY
    
    F.R. Khuri e S.H. Lippman, "Lung cancer chemoprevention", SEM SURG ON, 18(2), 2000, pp. 100-105
16. Khuri, FR; Nemunaitis, J; Ganly, I; Arseneau, J; Tannock, IF; Romel, L; Gore, M; Ironside, J; MacDougall, RH; Heise, C; Randlev, B; Gillenwater, AM; Bruso, P; Kaye, SB; Hong, WK; Kirn, DH
    A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
    NATURE MEDICINE
    
    F.R. Khuri et al., "A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer", NAT MED, 6(8), 2000, pp. 879-885
17. Kurie, JM; Lee, JS; Khuri, FR; Mao, L; Morice, RC; Lee, JJ; Walsh, GL; Broxson, A; Lippman, SM; Ro, JY; Kemp, BL; Liu, D; Fritsche, HA; Xu, XC; Lotan, R; Hong, WK
    N-(4-hydroxyphenyl)retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium
    CLINICAL CANCER RESEARCH
    
    J.M. Kurie et al., "N-(4-hydroxyphenyl)retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium", CLIN CANC R, 6(8), 2000, pp. 2973-2979
18. Khuri, FR; Kurie, JM
    Antisense approaches enter the clinic
    CLINICAL CANCER RESEARCH
    
    F.R. Khuri e J.M. Kurie, "Antisense approaches enter the clinic", CLIN CANC R, 6(5), 2000, pp. 1607-1610
19. Herbst, RS; Yano, S; Kuniyasu, H; Khuri, FR; Bucana, CD; Guo, F; Liu, D; Kemp, B; Lee, JJ; Hong, WK; Fidler, IJ
    Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma
    CLINICAL CANCER RESEARCH
    
    R.S. Herbst et al., "Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma", CLIN CANC R, 6(3), 2000, pp. 790-797
20. Zhou, X; Kemp, BL; Khuri, FR; Liu, D; Lee, JJ; Wu, WG; Hong, WK; Mao, L
    Prognostic implication of microsatellite alteration profiles in early-stage non-small cell lung cancer
    CLINICAL CANCER RESEARCH
    
    X. Zhou et al., "Prognostic implication of microsatellite alteration profiles in early-stage non-small cell lung cancer", CLIN CANC R, 6(2), 2000, pp. 559-565
21. Yen, N; Ioannides, CG; Xu, K; Swisher, SG; Lawrence, DD; Kemp, BL; El-Naggar, AK; Cristiano, RJ; Fang, BL; Glisson, BS; Hong, WK; Khuri, FR; Kurie, JM; Lee, JJ; Lee, JS; Merritt, JA; Mukhopadhyay, T; Nesbitt, JC; Nguyen, D; Perez-Soler, R; Pisters, KMW; Putnam, JB; Schrump, DS; Shin, DM; Walsh, GL; Roth, JA
    Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type p53 (Ad-p53)
    CANCER GENE THERAPY
    
    N. Yen et al., "Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type p53 (Ad-p53)", CANC GENE T, 7(4), 2000, pp. 530-536
22. Nemunaitis, J; Swisher, SG; Timmons, T; Connors, D; Mack, M; Doerksen, L; Weill, D; Wait, J; Lawrence, DD; Kemp, BL; Fossella, F; Glisson, BS; Hong, WK; Khuri, FR; Kurie, JM; Lee, JJ; Lee, JS; Nguyen, DM; Nesbitt, JC; Perez-Soler, R; Pisters, KMW; Putnam, JB; Richli, WR; Shin, DM; Walsh, GL; Merritt, J; Roth, J
    Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumorsof patients with non-small-cell lung cancer
    JOURNAL OF CLINICAL ONCOLOGY
    
    J. Nemunaitis et al., "Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumorsof patients with non-small-cell lung cancer", J CL ONCOL, 18(3), 2000, pp. 609-622
23. Khuri, FR; Lotan, R; Kemp, BL; Lippman, SM; Wu, H; Feng, L; Lee, JJ; Cooksley, CS; Parr, B; Chang, E; Walsh, GL; Lee, JS; Hong, WK; Xu, XC
    Retinoic acid receptor-beta as a prognostic indicator in stage I non-small-cell lung cancer
    JOURNAL OF CLINICAL ONCOLOGY
    
    F.R. Khuri et al., "Retinoic acid receptor-beta as a prognostic indicator in stage I non-small-cell lung cancer", J CL ONCOL, 18(15), 2000, pp. 2798-2804
24. Khuri, FR; Shin, DM; Glisson, BS; Lippman, SM; Hong, WK
    Treatment of patients with recurrent or metastatic squamous cell carcinomaof the head and neck: Current status and future directions
    SEMINARS IN ONCOLOGY
    
    F.R. Khuri et al., "Treatment of patients with recurrent or metastatic squamous cell carcinomaof the head and neck: Current status and future directions", SEMIN ONCOL, 27(4), 2000, pp. 25-33
25. Soria, JC; Jang, SJ; Khuri, FR; Hassan, K; Lin, D; Hong, WK; Mao, L
    Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication
    CANCER RESEARCH
    
    J.C. Soria et al., "Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication", CANCER RES, 60(15), 2000, pp. 4000-4004
26. Liu, NS; Spitz, MR; Kemp, BL; Cooksley, C; Fossella, FV; Lee, JS; Hong, WK; Khuri, FR
    Adenocarcinoma of the lung in young patients - The M. D. Anderson experience
    CANCER
    
    N.S. Liu et al., "Adenocarcinoma of the lung in young patients - The M. D. Anderson experience", CANCER, 88(8), 2000, pp. 1837-1841
27. Tang, XM; Khuri, FR; Lee, JJ; Kemp, BL; Liu, D; Hong, WK; Mao, L
    Hypermethylation of the death-associated protein (DAP) kinase promoter andaggressiveness in stage I non-small-cell lung cancer
    JOURNAL OF THE NATIONAL CANCER INSTITUTE
    
    X.M. Tang et al., "Hypermethylation of the death-associated protein (DAP) kinase promoter andaggressiveness in stage I non-small-cell lung cancer", J NAT CANC, 92(18), 2000, pp. 1511-1516
28. Izzo, JG; Khuri, FR; Hong, WK
    Adjuvant biological therapy of head and neck cancer
    STRATEGIES IN ADJUVANT THERAPY
    
    J.G. Izzo et al., "Adjuvant biological therapy of head and neck cancer", STRATEGIES IN ADJUVANT THERAPY, 2000, pp. 153-184
29. Khuri, FR; Tannous-Khuri, LR; Hong, WK
    Chemoprevention of lung cancer
    MULTIMODALITY TREATMENT OF LUNG CANCER
    
    F.R. Khuri et al., "Chemoprevention of lung cancer", LUNG BIOL H, 140, 2000, pp. 27-46
30. Garden, AS; Glisson, BS; Ang, KK; Morrison, WH; Lippman, SM; Byers, RM; Geara, F; Clayman, GL; Shin, DM; Callender, DL; Khuri, FR; Goepfert, H; Hong, WK; Peters, LJ
    Phase I/II trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: Toxicities and responses
    JOURNAL OF CLINICAL ONCOLOGY
    
    A.S. Garden et al., "Phase I/II trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: Toxicities and responses", J CL ONCOL, 17(8), 1999, pp. 2390-2395
31. Tseng, JE; Kemp, BL; Khuri, FR; Kurie, JH; Lee, JS; Zhou, X; Liu, D; Hong, WK; Mao, L
    Loss of Fhit is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers
    CANCER RESEARCH
    
    J.E. Tseng et al., "Loss of Fhit is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers", CANCER RES, 59(19), 1999, pp. 4798-4803
32. Swisher, SG; Roth, JA; Nemunaitis, J; Lawrence, DD; Kemp, BL; Carrasco, CH; Connors, DG; El-Naggar, AK; Fossella, F; Glisson, BS; Hong, WK; Khuri, FR; Kurie, JM; Lee, JJ; Lee, JS; Mack, M; Merritt, JA; Nguyen, DM; Nesbitt, JC; Perez-Soler, R; Pisters, KMW; Putnam, JB; Richli, WR; Savin, M; Schrump, DS; Shin, DM; Shulkin, A; Walsh, GL; Wait, J; Weill, D; Waugh, MKA
    Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer
    JOURNAL OF THE NATIONAL CANCER INSTITUTE
    
    S.G. Swisher et al., "Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer", J NAT CANC, 91(9), 1999, pp. 763-771
33. KHURI FR; FOSSELLA FV; LEE JS; MURPHY WK; SHIN DM; MARKOWITZ AB; GLISSON BS
    PHASE-II TRIAL OF RECOMBINANT IFN-ALPHA-2A WITH ETOPOSIDE CISPLATIN INDUCTION AND INTERFERON/MEGESTROL ACETATE MAINTENANCE IN EXTENSIVE SMALL-CELL LUNG-CANCER/
    Journal of interferon & cytokine research
    
    F.R. Khuri et al., "PHASE-II TRIAL OF RECOMBINANT IFN-ALPHA-2A WITH ETOPOSIDE CISPLATIN INDUCTION AND INTERFERON/MEGESTROL ACETATE MAINTENANCE IN EXTENSIVE SMALL-CELL LUNG-CANCER/", Journal of interferon & cytokine research, 18(4), 1998, pp. 241-245
34. SHIN DM; WALSH GL; SWISHER S; WIMBERLY A; SHIN HJC; RO JY; KHURI FR; LEE JS; HONG WK; KHOKHAR AR; PEREZSOLER R
    ANTITUMOR-ACTIVITY OF A LIPOSOME-ENTRAPPED CISPLATIN ANALOG (L-NDDP) ADMINISTERED INTRAPLEURALLY IN PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA (MPM)
    Annals of oncology
    
    D.M. Shin et al., "ANTITUMOR-ACTIVITY OF A LIPOSOME-ENTRAPPED CISPLATIN ANALOG (L-NDDP) ADMINISTERED INTRAPLEURALLY IN PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA (MPM)", Annals of oncology, 9, 1998, pp. 659-659
35. LEE JS; PISTERS KMW; KOMAKI R; GLISSON BS; PEREZSOLER R; KHURI FR; DELCLOS ME; FOSSELLA FV
    THE ROLE OF PACLITAXEL CARBOPLATIN CHEMOTHERAPY AS A PRIMARY-TREATMENT OF BRAIN METASTASES IN NONSMALL CELL LUNG-CANCER/
    Annals of oncology
    
    J.S. Lee et al., "THE ROLE OF PACLITAXEL CARBOPLATIN CHEMOTHERAPY AS A PRIMARY-TREATMENT OF BRAIN METASTASES IN NONSMALL CELL LUNG-CANCER/", Annals of oncology, 9, 1998, pp. 660-660
36. SHIN DM; GLISSON BS; KHURI FR; GINSBERG L; PAPADIMITRAKOPOULOU V; LEE JJ; LAWHORN K; GILLENWATER AM; ANG KK; CLAYMAN GL; CALLENDER DL; HONG WK; LIPPMAN SM
    PHASE-II TRIAL OF PACLITAXEL, IFOSFAMIDE, AND CISPLATIN IN PATIENTS WITH RECURRENT HEAD AND NECK SQUAMOUS-CELL CARCINOMA
    Journal of clinical oncology
    
    D.M. Shin et al., "PHASE-II TRIAL OF PACLITAXEL, IFOSFAMIDE, AND CISPLATIN IN PATIENTS WITH RECURRENT HEAD AND NECK SQUAMOUS-CELL CARCINOMA", Journal of clinical oncology, 16(4), 1998, pp. 1325-1330
37. SHIN DM; GLISSON BS; KHURI FR; HONG WK; LIPPMAN SM
    ROLE OF PACLITAXEL, IFOSFAMIDE, AND CISPLATIN IN PATIENTS WITH RECURRENT OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    Seminars in oncology
    
    D.M. Shin et al., "ROLE OF PACLITAXEL, IFOSFAMIDE, AND CISPLATIN IN PATIENTS WITH RECURRENT OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK", Seminars in oncology, 25(2), 1998, pp. 40-44
38. ROTH JA; SWISHER SG; LAWRENCE DD; KEMP BL; CARRASCO CH; ELNAGGAR AK; FOSSELA FV; GLISSON BS; HONG WK; KHURI FR; KURIE JM; NESBITT JC; PISTERS K; PUTNAM JB; SCHRUMP DS; SHIN DM; WALSH GL
    LOCAL AND SYSTEMIC STRATEGIES FOR GENE REPLACEMENT FOR CANCER
    British Journal of Cancer
    
    J.A. Roth et al., "LOCAL AND SYSTEMIC STRATEGIES FOR GENE REPLACEMENT FOR CANCER", British Journal of Cancer, 78(2), 1998, pp. 142-142
39. KURIE JM; LEE JS; MORICE RC; WALSH GL; KHURI FR; BROXSON A; RO JY; FRANKLIN WA; YU R; HONG WK
    AUTOFLUORESCENCE BRONCHOSCOPY IN THE DETECTION OF SQUAMOUS METAPLASIAAND DYSPLASIA IN CURRENT AND FORMER SMOKERS
    Journal of the National Cancer Institute
    
    J.M. Kurie et al., "AUTOFLUORESCENCE BRONCHOSCOPY IN THE DETECTION OF SQUAMOUS METAPLASIAAND DYSPLASIA IN CURRENT AND FORMER SMOKERS", Journal of the National Cancer Institute, 90(13), 1998, pp. 991-995
40. SPITZ MR; MCPHERSON RS; JIANG H; HSU TC; TRIZNA Z; LEE JJ; LIPPMAN SM; KHURI FR; STEFFENBATEY L; CHAMBERLAIN RM; SCHANTZ SP; HONG WK
    CORRELATES OF MUTAGEN SENSITIVITY IN PATIENTS WITH UPPER AERODIGESTIVE TRACT CANCER
    Cancer epidemiology, biomarkers & prevention
    
    M.R. Spitz et al., "CORRELATES OF MUTAGEN SENSITIVITY IN PATIENTS WITH UPPER AERODIGESTIVE TRACT CANCER", Cancer epidemiology, biomarkers & prevention, 6(9), 1997, pp. 687-692
41. KHURI FR; KURIE JM; HONG WK
    CHEMOPREVENTION OF RESPIRATORY-TRACT CANCER
    Hematology/oncology clinics of North America
    
    F.R. Khuri et al., "CHEMOPREVENTION OF RESPIRATORY-TRACT CANCER", Hematology/oncology clinics of North America, 11(3), 1997, pp. 387
42. SHIN DM; GLISSON BS; KHURI FR; GINSBERG L; LAWHORN K; HONG WK; LIPPMAN SM
    RECENT ADVANCES IN PACILITAXEL-CONTAINING CHEMOTHERAPY FOR RECURRENT OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    Seminars in oncology
    
    D.M. Shin et al., "RECENT ADVANCES IN PACILITAXEL-CONTAINING CHEMOTHERAPY FOR RECURRENT OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK", Seminars in oncology, 24(6), 1997, pp. 33-37
43. LEE JS; PISTERS KMW; KOMAKI R; GLISSON BS; KHURI FR; SCHEA R; FOSSELLA FV
    PACLITAXEL CARBOPLATIN CHEMOTHERAPY AS PRIMARY-TREATMENT OF BRAIN METASTASES IN NONSMALL CELL LUNG-CANCER - A PRELIMINARY-REPORT/
    Seminars in oncology
    
    J.S. Lee et al., "PACLITAXEL CARBOPLATIN CHEMOTHERAPY AS PRIMARY-TREATMENT OF BRAIN METASTASES IN NONSMALL CELL LUNG-CANCER - A PRELIMINARY-REPORT/", Seminars in oncology, 24(4), 1997, pp. 52-55
44. KHURI FR; LIPPMAN SM; SPITZ MR; LOTAN R; HONG WK
    MOLECULAR EPIDEMIOLOGY AND RETINOID CHEMOPREVENTION OF HEAD AND NECK-CANCER
    Journal of the National Cancer Institute
    
    F.R. Khuri et al., "MOLECULAR EPIDEMIOLOGY AND RETINOID CHEMOPREVENTION OF HEAD AND NECK-CANCER", Journal of the National Cancer Institute, 89(3), 1997, pp. 199-211
45. MAO L; LEE JS; KURIE JM; FAN YH; LIPPMAN SM; LEE JJ; RO JY; BROXSON A; YU R; MORICE RC; KEMP BL; KHURI FR; WALSH GL; HITTELMAN WN; HONG WK
    CLONAL GENETIC ALTERATIONS IN THE LUNGS OF CURRENT AND FORMER SMOKERS
    Journal of the National Cancer Institute
    
    L. Mao et al., "CLONAL GENETIC ALTERATIONS IN THE LUNGS OF CURRENT AND FORMER SMOKERS", Journal of the National Cancer Institute, 89(12), 1997, pp. 857-862
46. KHURI FR; HONG WK; LEE JS
    NEW DIRECTIONS IN LUNG-CANCER - CHEMOPREVENTION
    Seminars in respiratory and critical care medicine
    
    F.R. Khuri et al., "NEW DIRECTIONS IN LUNG-CANCER - CHEMOPREVENTION", Seminars in respiratory and critical care medicine, 17(4), 1996, pp. 323-334
47. KHURI FR; CHO YH; TALMAGE DA
    RETINOIC ACID-INDUCED TRANSITION FROM PROTEIN-KINASE C-BETA TO PROTEIN-KINASE C-ALPHA IN DIFFERENTIATED F9 CELLS - CORRELATION WITH ALTEREDREGULATION OF PROTOONCOGENE EXPRESSION BY PHORBOL ESTERS
    Cell growth & differentiation
    
    F.R. Khuri et al., "RETINOIC ACID-INDUCED TRANSITION FROM PROTEIN-KINASE C-BETA TO PROTEIN-KINASE C-ALPHA IN DIFFERENTIATED F9 CELLS - CORRELATION WITH ALTEREDREGULATION OF PROTOONCOGENE EXPRESSION BY PHORBOL ESTERS", Cell growth & differentiation, 7(5), 1996, pp. 595-602